(FILES) The company logo of German chemical giant Bayer is pictured at the company's site in Berlin on March 4, 2026. German agrichemical and pharmaceutical giant Bayer said on May 6, 2026 it would buy experimental glaucoma drug maker Perfuse Therapeutics in a deal worth up to $2.45 billion (2.09 billion euros). (Photo by Tobias SCHWARZ / AFP via Getty Images)